| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |